financetom
Business
financetom
/
Business
/
Update: Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says
May 22, 2024 12:14 PM

01:53 PM EDT, 05/22/2024 (MT Newswires) -- (Updates with Johnson & Johnson's ( JNJ ) response.)

Johnson & Johnson ( JNJ ) is alleged to have engaged in certain fraudulent transactions and "bad faith bankruptcy filings" that have hindered or delayed individuals who developed cancer from using the company's asbestos-laden talc products from having their day in court, according to a lawsuit filed Wednesday in a federal district court in New Jersey.

"Our focus has been and will remain reaching a full, fair and final resolution of this litigation, and allowing the claimants to speak for themselves," Erik Haas, Johnson & Johnson's ( JNJ ) worldwide vice president of litigation, told MT Newswires. "We will immediately move to dismiss this latest 'Hail Mary' frivolous filing."

Price: 153.72, Change: +2.48, Percent Change: +1.64

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MoonLake Immunotherapeutics Starts Three New Clinical Trials Evaluating Sonelokimab in Inflammatory Diseases
MoonLake Immunotherapeutics Starts Three New Clinical Trials Evaluating Sonelokimab in Inflammatory Diseases
Jan 8, 2025
11:43 AM EST, 01/08/2025 (MT Newswires) -- MoonLake Immunotherapeutics ( MLTX ) said Wednesday that it has screened patients for for three new clinical trials targeting three new indications to assess sonelokimab, an investigational Nanobody aimed at treating inflammatory diseases. The clinical program for sonelokimab now includes patients with adolescent hidradenitis suppurativa, or HS, palmoplantar pustulosis, or PPP, and axial...
What's Going On With FuboTV Stock After Disney Deal?
What's Going On With FuboTV Stock After Disney Deal?
Jan 8, 2025
FuboTV Inc ( FUBO ) shares recently saw a 300% surge driven by the announcement of a new partnership with Walt Disney Co ( DIS ) . What To Know: The agreement, which positions Disney ( DIS ) to own 70% of a combined FuboTV ( FUBO ) and Hulu+LiveTV entity, is expected to close within 12 to 18 months....
Air Industries Receives $5.9 Million US Air Force Contract for Aircraft Flight Control Assemblies
Air Industries Receives $5.9 Million US Air Force Contract for Aircraft Flight Control Assemblies
Jan 8, 2025
11:49 AM EST, 01/08/2025 (MT Newswires) -- Air Industries Group ( AIRI ) said Wednesday it has received a $5.9 million US Air Force contract for flight control assemblies, or actuators, for the F-5/T-38 aircraft. Shares of Air Industries ( AIRI ) were up 0.2% in recent Wednesday trading. Price: 4.31, Change: +0.01, Percent Change: +0.23 ...
MoonLake's Three New Trials Will Expand Sonelokimab's Potential, Wedbush Says
MoonLake's Three New Trials Will Expand Sonelokimab's Potential, Wedbush Says
Jan 8, 2025
11:53 AM EST, 01/08/2025 (MT Newswires) -- MoonLake Immunotherapeutics' ( MLTX ) three new studies of the company's nanobody sonelokimab in three new indications are positive progress in its efforts to expand the market opportunity for the candidate drug, Wedbush said Wednesday in a note to clients. MoonLake said Wednesday that sonelokimab's clinical program now includes people with adolescent hidradenitis...
Copyright 2023-2026 - www.financetom.com All Rights Reserved